z-logo
Premium
Inhibitor development in an elderly patient with severe factor IX deficiency being treated with ALPROLIX, a recombinant factor IX Fc fusion protein
Author(s) -
Comerford Claire,
Crowley Maeve,
Collins Norma,
BoothFleming Brid,
RyanHall Annmarie,
Firtear Brid,
O’Shea Susan,
Duggan Cleona
Publication year - 2021
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.14198
Subject(s) - cork , haemophilia , medicine , university hospital , haemophilia a , pediatrics , family medicine , materials science , composite material

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom